ArticleCancers2020

Trastuzumab Emtansine Plus Non-Pegylated Liposomal Doxorubicin in HER2-Positive Metastatic Breast Cancer (Thelma): A Single-Arm, Multicenter, Phase Ib Trial.

Elena López-Miranda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.